Clinical Trial Update: A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of CM-AT in children with autism has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• CM-AT

Snippet

Sponsor: Curemark | Conditions: Autism | Phase 3 | Status: COMPLETED | Results posted: 2022-10-26